🇺🇸 FDA
Pipeline program

Cemiplimab

ACTG A5370

Phase 2 mab terminated

Quick answer

Cemiplimab for HIV Infections is a Phase 2 program (mab) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
HIV Infections
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials